Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Other Non-Current Liabilities (2023 - 2024)

Artiva Biotherapeutics (ARTV) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $73000.0 as the latest value for Q4 2024.

  • For Q4 2024, Other Non-Current Liabilities fell 99.71% year-over-year to $73000.0; the TTM value through Dec 2024 reached $73000.0, down 99.71%, while the annual FY2024 figure was $73000.0, 99.71% down from the prior year.
  • Other Non-Current Liabilities hit $73000.0 in Q4 2024 for Artiva Biotherapeutics, roughly flat from $73000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $27.7 million in Q2 2024 and bottomed at $73000.0 in Q3 2024.